Mutation in TET2 in Myeloid Cancers
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mutation of tet methylcytosine dioxygenase 2 (encoded by TET2) drives myeloid malignancy initiation and progression1–3.”
From RNA m5C oxidation by TET2 regulates chromatin state and leukaemogenesis (2024) · cites this paper as [1]
In the citing paper
“A number of 2-oxoglutarate-dependent enzymes that act on chromatin are themselves targets of inactivating mutations in cancer, including the UTX H3K27 demethylase (also called KDM6A), JARID1C H3K4 demethylase (KDM5C), and TET2, making them attractive candidates for pathogenically relevant inhibition by succinate, fumarate, and R-2HG (Abdel-Wahab et al., 2009; Dalgliesh et al., 2010; Tefferi et al”
From Influence of Metabolism on Epigenetics and Disease (2013) · cites this paper as Tefferi et al., 2009
Citations
Cites
Mutation in TET2 in Myeloid Cancers
Delhommeau, F., Dupont, S., Valle, V. D., James, C., Trannoy, S., Massé, A., Kosmider, O., Le Couedic, J.-P., Robert, F., Alberdi, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810069 · Cited by 1,776
Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies
Abdel-Wahab, O., Mullally, A., Hedvat, C., Garcia-Manero, G., Patel, J., Wadleigh, M., Malinge, S., Yao, J., Kilpivaara, O., Bhat, R., et al. (2009) · Blood · doi:10.1182/blood-2009-03-210039 · Cited by 727
Self-citationAcquired mutations in TET2 are common in myelodysplastic syndromes
Langemeijer, S. M. C., Kuiper, R. P., Berends, M., Knops, R., Aslanyan, M. G., Massop, M., Stevens-Linders, E., van Hoogen, P., van Kessel, A. G., Raymakers, R. A. P., et al. (2009) · Nature Genetics · doi:10.1038/ng.391 · Cited by 680
Tefferi, A., Pardanani, A., Lim, K.-H., Abdel-Wahab, O., Lasho, T. L., Patel, J., Gangat, N., Finke, C. M., Schwager, S., Mullally, A., et al. (2009) · Leukemia · doi:10.1038/leu.2009.47 · Cited by 425
Self-citationTefferi, A., Lim, K.-H., Abdel-Wahab, O., Lasho, T. L., Patel, J., Patnaik, M. M., Hanson, C. A., Pardanani, A., Gilliland, D. G., & Levine, R. L. (2009) · Leukemia · doi:10.1038/leu.2009.59 · Cited by 268
Self-citationFrequent TET2 mutations in systemic mastocytosis: clinical, KITD816V and FIP1L1-PDGFRA correlates
Tefferi, A., Levine, R. L., Lim, K.-H., Abdel-Wahab, O., Lasho, T. L., Patel, J., Finke, C. M., Mullally, A., Li, C.-Y., Pardanani, A., et al. (2009) · Leukemia · doi:10.1038/leu.2009.37 · Cited by 252
Self-citationClonal heterogeneity in polycythemia vera patients with JAK2 exon12 and JAK2-V617F mutations
Li, S., Kralovics, R., De Libero, G., Theocharides, A., Gisslinger, H., & Skoda, R. C. (2008) · Blood · doi:10.1182/blood-2007-09-111971 · Cited by 108
Research works printed but not linked: 1
- 10.1056/NEJMoa0810069 · DOI · Paper page
Cited by
Influence of Metabolism on Epigenetics and Disease
Kaelin, W. G., & McKnight, S. L. (2013) · Cell · doi:10.1016/j.cell.2013.03.004 · Cited by 920
“A number of 2-oxoglutarate-dependent enzymes that act on chromatin are themselves targets of inactivating mutations in cancer, including the UTX H3K27 demethylase (also called KDM6A), JARID1C H3K4 demethylase (KDM5C), and TET2, making them attractive candidates for pathogenically relevant inhibition by succinate, fuma…”
Tefferi, A. (2010) · Leukemia · doi:10.1038/leu.2010.69 · Cited by 534
Self-citationRampal, R., Al-Shahrour, F., Abdel-Wahab, O., Patel, J. P., Brunel, J.-P., Mermel, C. H., Bass, A. J., Pretz, J., Ahn, J., Hricik, T., et al. (2014) · Blood · doi:10.1182/blood-2014-02-554634 · Cited by 428
Self-citationPrognostic Significance of ASXL1 Mutations in Patients With Myelodysplastic Syndromes
Thol, F., Friesen, I., Damm, F., Yun, H., Weissinger, E. M., Krauter, J., Wagner, K., Chaturvedi, A., Sharma, A., Wichmann, M., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.4938 · Cited by 277
Distinct roles of the methylcytosine oxidases Tet1 and Tet2 in mouse embryonic stem cells
Huang, Y., Chavez, L., Chang, X., Wang, X., Pastor, W. A., Kang, J., Zepeda-Martínez, J. A., Pape, U. J., Jacobsen, S. E., Peters, B., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1322921111 · Cited by 259
Thol, F., Weissinger, E. M., Krauter, J., Wagner, K., Damm, F., Wichmann, M., Gohring, G., Schumann, C., Bug, G., Ottmann, O., et al. (2010) · Haematologica · doi:10.3324/haematol.2010.025494 · Cited by 191
Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Fenaux, P., Haase, D., Sanz, G. F., Santini, V., & Buske, C. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu180 · Cited by 170
Brecqueville, M., Rey, J., Bertucci, F., Coppin, E., Finetti, P., Carbuccia, N., Cervera, N., Gelsi‐Boyer, V., Arnoulet, C., Gisserot, O., et al. (2012) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.21960 · Cited by 158
TET2 guards against unchecked BATF3-induced CAR T cell expansion
Jain, N., Zhao, Z., Feucht, J., Koche, R., Iyer, A., Dobrin, A., Mansilla-Soto, J., Yang, J., Zhan, Y., Lopez, M., et al. (2023) · Nature · doi:10.1038/s41586-022-05692-z · Cited by 154
Jawhar, M., Schwaab, J., Schnittger, S., Sotlar, K., Horny, H. ‐., Metzgeroth, G., Müller, N., Schneider, S. O., Naumann, N., Walz, C., et al. (2015) · Leukemia · doi:10.1038/leu.2015.4 · Cited by 164
Combined landscape of single-nucleotide variants and copy number alterations in clonal hematopoiesis
Saiki, R., Momozawa, Y., Nannya, Y., Nakagawa, M. M., Ochi, Y., Yoshizato, T., Terao, C., Kuroda, Y., Shiraishi, Y., Chiba, K., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01411-9 · Cited by 148
Tet1 and 5-hydroxymethylation: A genome-wide view in mouse embryonic stem cells
Wu, H., & Zhang, Y. (2011) · Cell Cycle · doi:10.4161/cc.10.15.16930 · Cited by 127
The early‐life social environment and DNA methylation
Szyf, M. (2012) · Clinical Genetics · doi:10.1111/j.1399-0004.2012.01843.x · Cited by 120
TET2-mediated mRNA demethylation regulates leukemia stem cell homing and self-renewal
Li, Y., Xue, M., Deng, X., Dong, L., Nguyen, L. X. T., Ren, L., Han, L., Li, C., Xue, J., Zhao, Z., et al. (2023) · Cell Stem Cell · doi:10.1016/j.stem.2023.07.001 · Cited by 110
Independent prognostic variables in acute myeloid leukaemia
Smith, M. L., Hills, R. K., & Grimwade, D. J. (2010) · Blood Reviews · doi:10.1016/j.blre.2010.10.002 · Cited by 112
RNA m5C oxidation by TET2 regulates chromatin state and leukaemogenesis
Zou, Z., Dou, X., Li, Y., Zhang, Z., Wang, J., Gao, B., Xiao, Y., Wang, Y., Zhao, L., Sun, C., et al. (2024) · Nature · doi:10.1038/s41586-024-07969-x · Cited by 103
Meyer, S. E., Qin, T., Muench, D. E., Masuda, K., Venkatasubramanian, M., Orr, E., Suarez, L., Gore, S. D., Delwel, R., Paietta, E., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0008 · Cited by 101
Disruption of SUV39H1 -Mediated H3K9 Methylation Sustains CAR T-cell Function
Jain, N., Zhao, Z., Koche, R. P., Antelope, C., Gozlan, Y., Montalbano, A., Brocks, D., Lopez, M., Dobrin, A., Shi, Y., et al. (2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-1319 · Cited by 95
Kallin, E. M., Rodríguez-Ubreva, J., Christensen, J., Cimmino, L., Aifantis, I., Helin, K., Ballestar, E., & Graf, T. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.08.007 · Cited by 92
“Tet2 mutations have been described in several types of hematopoietic disorders (Tefferi, 2010), including acute myeloid leukemia (AML), chronic myelomonocytic leukemia (CMML), and myelodysplastic syndrome (MDS) (Langemeijer et al., 2009; Tefferi et al., 2009).”
BackgroundHarnessing Hematopoietic Stem Cell Low Intracellular Calcium Improves Their Maintenance In Vitro
Luchsinger, L. L., Strikoudis, A., Danzl, N. M., Bush, E. C., Finlayson, M. O., Satwani, P., Sykes, M., Yazawa, M., & Snoeck, H.-W. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2019.05.002 · Cited by 91
Perez, B., Kosmider, O., Cassinat, B., Renneville, A., Lachenaud, J., Kaltenbach, S., Bertrand, Y., Baruchel, A., Chomienne, C., Fontenay, M., et al. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08393.x · Cited by 81
Ten Eleven Translocation Enzymes and 5-Hydroxymethylation in Mammalian Development and Cancer
Kinney, S. R. M., & Pradhan, S. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-9967-2_3 · Cited by 76
Ge, L., Zhang, R.-P., Wan, F., Guo, D.-Y., Wang, P., Xiang, L.-X., & Shao, J.-Z. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.01061-13 · Cited by 68
Calcium regulation of stem cells
Snoeck, H. (2020) · EMBO Reports · doi:10.15252/embr.202050028 · Cited by 61
Liquid biopsies: DNA methylation analyses in circulating cell-free DNA
Zeng, H., He, B., Yi, C., & Peng, J. (2018) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2018.02.007 · Cited by 60
5-Hydroxymethylcytosine and disease
Wang, J., Tang, J., Lai, M., & Zhang, H. (2014) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2014.09.003 · Cited by 60
Role of somatic cancer mutations in human protein lysine methyltransferases
Kudithipudi, S., & Jeltsch, A. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.08.002 · Cited by 57
Epigenetic abnormalities in myeloproliferative neoplasms: a target for novel therapeutic strategies
Mascarenhas, J. O., Roper, N., Chaurasia, P., & Hoffman, R. (2011) · Clinical Epigenetics · doi:10.1007/s13148-011-0050-6 · Cited by 56
The functional mechanisms of mutations in myelodysplastic syndrome
Nagata, Y., & Maciejewski, J. P. (2019) · Leukemia · doi:10.1038/s41375-019-0617-3 · Cited by 51
Zeng, H., He, H., Guo, L., Li, J., Lee, M., Han, W., Guzman, A. G., Zang, S., Zhou, Y., Zhang, X., et al. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.09.013 · Cited by 38
Mechanisms of myeloid leukemogenesis: Current perspectives and therapeutic objectives
Bouligny, I. M., Maher, K. R., & Grant, S. (2022) · Blood Reviews · doi:10.1016/j.blre.2022.100996 · Cited by 47
Gasparini, V. R., Binatti, A., Coppe, A., Teramo, A., Vicenzetto, C., Calabretto, G., Barilà, G., Barizza, A., Giussani, E., Facco, M., et al. (2020) · Blood Cancer Journal · doi:10.1038/s41408-020-0309-2 · Cited by 38
SWI/SNF Subunits SMARCA4, SMARCD2 and DPF2 Collaborate in MLL-Rearranged Leukaemia Maintenance
Cruickshank, V. A., Sroczyńska, P., Sankar, A., Miyagi, S., Rundsten, C. F., Johansen, J. V., & Helin, K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142806 · Cited by 31
Kraus, T. F. J., Greiner, A., Steinmaurer, M., Dietinger, V., Guibourt, V., & Kretzschmar, H. A. (2015) · Journal of Cancer · doi:10.7150/jca.12010 · Cited by 33
Guo, X., Long, J., Zeng, C., Michailidou, K., Ghoussaini, M., Bolla, M. K., Wang, Q., Milne, R. L., Shu, X., Cai, Q., et al. (2015) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-0363 · Cited by 34
CALR mutation screening in pediatric primary myelofibrosis
An, W., Wan, Y., Guo, Y., Chen, X., Ren, Y., Zhang, J., Chang, L., Wei, W., Zhang, P., & Zhu, X. (2014) · Pediatric Blood & Cancer · doi:10.1002/pbc.25211 · Cited by 25
Gill, H., Ip, H., Yim, R., Tang, W., Pang, H., Lee, P., Leung, G. M. K., Li, J., Tang, K., So, J. C. C., et al. (2018) · Annals of Hematology · doi:10.1007/s00277-018-3563-7 · Cited by 24
Analysis of genome-wide in cell free DNA methylation: progress and prospect
Liu, Z., Wang, Z., Jia, E., Ouyang, T., Pan, M., Lu, J., Ge, Q., & Bai, Y. (2019) · The Analyst · doi:10.1039/c9an00935c · Cited by 23
Mutations profile of polycythemia vera and essential thrombocythemia among Japanese children
Ismael, O., Shimada, A., Hama, A., Sakaguchi, H., Doisaki, S., Muramatsu, H., Yoshida, N., Ito, M., Takahashi, Y., Akita, N., et al. (2011) · Pediatric Blood & Cancer · doi:10.1002/pbc.23409 · Cited by 20
Intestinal Microbes and Hematological Malignancies
Zhu, Y., Yang, Q., Yang, Q. Z., He, Y., & Zhou, W. (2023) · Cancers · doi:10.3390/cancers15082284 · Cited by 19
Role of Vitamin C in Targeting Cancer Stem Cells and Cellular Plasticity
Lee, Y. (2023) · Cancers · doi:10.3390/cancers15235657 · Cited by 19
Chen, S., Yan, X., Zhou, G., & Chen, Z. (2017) · Wiley eBooks · doi:10.1002/9781119000822.hfcm011 · Cited by 15
Tet oncogene family member 2 gene alterations in childhood acute myeloid leukemia
Li, M., Yang, Y., Lee, N., Jou, S., Lu, M., Chang, H., Lin, K., Peng, C., & Lin, D. (2015) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2015.08.002 · Cited by 13
Dambruoso, I., Boni, M., Rossi, M., Zappasodi, P., Calvello, C., Zappatore, R., Cavigliano, P. M., Giardini, I., Rocca, B., Caresana, M., et al. (2012) · Cancer Genetics · doi:10.1016/j.cancergen.2012.03.004 · Cited by 12
Merchant, S. (2021) · International review of cytology · doi:10.1016/bs.ircmb.2021.09.002 · Cited by 19
Tefferi, A. (2010) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428191003605313 · Cited by 12
Self-citationYang, Z., & Jiang, H. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03522-x · Cited by 10
Bastie, J.-N., Aucagne, R., Droin, N. M., Solary, É., & Delva, L. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-0956-y · Cited by 9
Research progress on gene mutations and drug resistance in leukemia
Ma, X., Xu, J., Wang, Y., Fleishman, J. S., Bing, H., Yu, B., Li, Y., Bo, L., Zhang, S., Chen, Z., et al. (2024) · Drug Resistance Updates · doi:10.1016/j.drup.2024.101195 · Cited by 10
Lee, K., Hong, C.-L., Dissanayake, W. M., Kulzhanova, G., Pfeffer, A. N., Li, H., Sivakumar, S., Yin, Z., Quarato, E. R., Benoodt, L., et al. (2026) · Blood · doi:10.1182/blood.2024028031 · Cited by 8
Guo, Y., Yu, H., Li, J., Liu, K., Han, M., Tang, Y., Li, S., Li, X., Wu, H., & Chen, D. (2025) · Neoplasia · doi:10.1016/j.neo.2025.101166 · Cited by 4
Genetic Alterations and Their Clinical Implications in Acute Myeloid Leukemia
Hou, H., Chou, W., & Tie, H.-F. (2011) · InTech eBooks · doi:10.5772/26421 · Cited by 5
Frequency of heterozygous TET2 deletions in myeloproliferative neoplasms
Najfeld, V., & Tripodi, J. (2010) · Cancer Management and Research · doi:10.2147/cmar.s12829 · Cited by 3
RNA methylation: where to from here for hematologic malignancies?
Guirguis, A. A. (2024) · Experimental Hematology · doi:10.1016/j.exphem.2024.104694 · Cited by 2
Villa, O., Mallo, M., Kosyakova, N., Salido, M., Liehr, T., Martinez-Aviles, L. M., Pedro, C., García‐Aragonés, M., Espinet, B., Bellosillo, B., et al. (2011) · Leukemia Research · doi:10.1016/j.leukres.2011.05.027 · Cited by 2
Active DNA Demethylation in Development, Human Disease, and Cancer
Tricarico, R., & Bellacosa, A. (2016) · Springer eBooks · doi:10.1007/978-4-431-55873-6_21 · Cited by 2
Vetro, C., Haferlach, C., Haferlach, T., Zenger, M., Nadarajah, N., Kern, W., & Meggendorfer, M. (2016) · Leukemia · doi:10.1038/leu.2016.158 · Cited by 1
Acute myeloid leukaemia - therapy - past, present and future
Faduola, P., Hakim, A. J., Mansnérus, J., Imai, A., & Neill, R. O. (2013) · Translational Biomedicine
Syndromes myélodysplasiques et leucémies secondaires. Généralités, diagnostic et classification
Park, S., Cluzeau, T., Fenaux, P., & Dreyfus, F. (2014) · Cited by 1
Chen, S., Yan, X., Zhou, G., & Zhu, C. H. (2022) · Wiley eBooks · doi:10.1002/9781119000822.hfcm011.pub2
Mei, L., Hu, C., Jin, G., Ge, C., Zhu, Y., Li, D., Peng, W., Li, H., Xu, X., Jiang, Y., et al. (2025) · Human Genomics · doi:10.1186/s40246-025-00748-3
Exercise-Induced Metabolites Influence Health via Epigenetic Modifications
Leng, M., Sun, S., & Cao, Y. (2025) · Epigenetics and human health · doi:10.1007/978-3-032-08045-5_9
Caractérisation moléculaire des syndromes myéloprolifératifs non leucémie myéloïde chronique
Brecqueville, M. (2013) · theses.fr (ABES) · doi:10.70675/a2deced0zcf93z45a7z9848z9906dfb5401a
Coppin, E. (2015) · theses.fr (ABES) · doi:10.70675/6957c36dz8f27z48f3z8280z053c2d8e66ec
Rôle de la calréticuline dans les néoplasmes myéloprolifératifs
El-Khoury, M. (2016) · theses.fr (ABES) · doi:10.70675/e4cbd01dz8d78z44f3zad7dzfa7300e6a7c6
Mechanism of Action of Interferon in the Treatment of JAK2V617F-Positive Myeloproliferative Neoplasm
Dagher, T. (2021) · theses.fr (ABES) · doi:10.70675/70385a66zf181z4e65z9833z84f2ea720612
Metadata
- Authors
- Tefferi, A., Lim, K. H., & Levine, R. L.
- Affiliations
- Mayo Clinic (US)
- Memorial Sloan Kettering Cancer Center (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2009-09-10
- Volume
- 361
- Issue
- 11
- Pages
- 1117-1118
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1520064074
- Cited by
- 66
- References
- 7
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 3 · 2023: 5 · 2022: 2 · 2021: 3 · 2020: 3 · 2019: 4 · 2018: 2 · 2017: 1 · 2016: 4 · 2015: 6 · 2014: 8 · 2013: 3 · 2012: 6
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- TET2, genetic mutations, myeloid neoplasms, myelodysplastic syndrome, myeloproliferative neoplasms, epigenetic regulators
- MeSH terms
- DNA-Binding Proteins, Humans, Leukemia, Myeloid, Mutation, Myelodysplastic Syndromes, Myeloproliferative Disorders, Proto-Oncogene Proteins, Genes, Tumor Suppressor, Disease Progression, Dioxygenases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.